Search for: "Mylan, Inc."
Results 261 - 280
of 673
Sort by Relevance
|
Sort by Date
5 Mar 2015, 5:52 am
Mylan Pharmaceutical, Inc., ___ F. [read post]
26 Jan 2015, 4:03 am
.* JUST OUT - Molecular weights at the Supreme Court - Teva v SandozThe IPKat has already covered the UK litigation of Generics (t/a Mylan) v Yeda/Teva, in which a patent that covered glatiramer acetate was held valid even though the claims specified a particular molecular weight range without specifying what method was used to measure that weight (here, here, and here). [read post]
22 Jan 2015, 1:47 pm
Mylan claim construction); see also Grant Decl. [read post]
16 Jan 2015, 9:39 am
Mylan Inc. et al, 1-14-cv-00935 (DED January 14, 2015, Order) (Stark, J.) [read post]
11 Jan 2015, 9:59 pm
Mylan Inc. et al. 1:15-cv-00026; filed January 8, 2015 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Mylan Inc.; Agila Specialties Private Ltd.; Mylan Pharmaceuticals Inc. [read post]
11 Dec 2014, 7:58 am
Mylan Inc. recently announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. [read post]
5 Dec 2014, 4:02 am
Mylan Inc., No. 11 C 1285, Slip Op. [read post]
30 Nov 2014, 7:48 pm
.; Mylan Inc. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
6 Nov 2014, 5:00 am
Mylan, Inc., 661 F. [read post]
1 Nov 2014, 12:47 pm
Mylan Pharmaceuticals Inc., C.A. [read post]
21 Oct 2014, 12:00 am
In Hospira UK Ltd v Genentech Inc[2014] EWHC 1094 (Pat), noted by the IPKat here, Birss J had to deal with inventive step of an ‘incremental’ invention, and he found the inventive concept, which related to a dosage regimen, to be obvious. [read post]
13 Oct 2014, 8:46 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc.; Natco Pharma Ltd. [read post]
13 Oct 2014, 9:01 am
Since then, no generic company has gained approval by the Food and Drug Administration to market a generic version of the drug, although the FDA in August agreed to review a new application from one of the generic firms — Momenta Pharmaceuticals, Inc. [read post]
10 Oct 2014, 1:16 pm
Defendants argued that under Mylan Labs., Inc. v. [read post]
1 Sep 2014, 7:04 am
. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
18 Aug 2014, 6:48 am
Mylan Pharmaceuticals, Inc., et al., Civil Action No. 08-889-SLR (D.Del., August 14, 2014), the Court granted defendants’ motion for partial summary judgment of no willfulness with respect to their infringement of the patents-in-suit based upon defendants’ at risk launch of their generic versions of plaintiffs’ Amrix® products. [read post]
18 Aug 2014, 2:49 am
Mylan Inst. [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global… [read post]
